granted
on 07 Feb 2024
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
90860790 filed on 02th Aug 2021
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical use; pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies
No 90860790
No Service/Collective Mark
No 00160164-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
09th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
07th Feb 2024 | SOU TEAS EXTENSION RECEIVED |
07th Feb 2024 | SOU EXTENSION 2 FILED |
07th Feb 2024 | SOU EXTENSION 2 GRANTED |
08th Sep 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
08th Sep 2023 | ITU LETTER MAILED, NO RESPONSE REQUIRED |
31st Aug 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
29th Aug 2023 | SOU TEAS EXTENSION RECEIVED |
29th Aug 2023 | SOU EXTENSION 1 FILED |
29th Aug 2023 | SOU EXTENSION 1 GRANTED |